Medizinische Hochschule Hannover (MHH) / Hannover Medical School

University / College

Location: Hannover, Germany (DE)

ISNI: 0000000095299877

ROR: https://ror.org/00f2yqf98

Show on Map:

Publications

(1,356)

Research Grants

(3)

Stereotactic body radiotherapy of adrenal metastases-A dose-finding study (2022) Buergy D, Wuerschmidt F, Gkika E, Hoerner-Rieber J, Knippen S, Gerum S, Balermpas P, et al. Journal article Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group (2022) Bakhuizen JJ, Hanson H, Van De Tuin K, Lalloo F, Tischkowitz M, Wadt K, Doergeloh BB, et al. Conference contribution Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany (2022) Mohr P, Scherrer E, Assaf C, Bender M, Berking C, Chandwani S, Eigentler T, et al. Journal article The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase (2022) Karow A, Göhring G, Sembill S, Lutterloh F, Neuhaus F, Callies S, Schirmer E, et al. Journal article Non-invasive imaging as the cornerstone of cardiovascular precision medicine (2022) Achenbach S, Fuchs F, Goncalves A, Kaiser-Albers C, Ali ZA, Bengel FM, Dimmeler S, et al. Journal article Noncoding RNA in the cardiovascular system: Collaborative research centre/transregio (SFB-TRR 267) Nicht kodierende Ribonukleinsäure im kardiovaskulären System: Sonderforschungsbereich-Transregio (SFB-TRR 267) (2022) Engelhardt S, Dimmeler S, Heim C, Baer C, Boettger T, Boon R, Brandes RP, et al. Journal article, Review article The prognostic impact of Claudin 6 in papillary renal cell carcinoma (2022) Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article cMET: a prognostic marker in papillary renal cell carcinoma? (2022) Erlmeier F, Bruecher B, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C (2022) De Gregorio A, Janni W, Friedl TWP, Nitz U, Rack B, Schneeweiss A, Kates R, et al. Journal article Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer (2022) Ramachandran D, Dennis J, Fachal L, Schurmann P, Bousset K, Huelse F, Mao Q, et al. Journal article

‹ 1 ... 26 27 28 29 30 ... 136 ›